IGHE and neoplasm: To investigate the role of MCs mediators, tumor cells were treated with resting MC's supernatant obtained without IgE crosslinking as well as activated MC's supernatant obtained from crosslinking of IgE bound to FcεRI receptors by allergen (DNP-BSA-100 ng/ml).